Tag: Prasad Adusumilli
Key Findings from the CAR T-Cell Study Presented at the 2019...
By Prasad S. Adusumilli, MD, FACS, FCCP
Posted: November 12, 2019
My colleagues and I conducted a phase I clinical trial of mesothelin-targeted chimeric antigen receptor...
